Home

Background

Statistics

Projects

Forum

Contacts

News

Arab Republic of Egypt
Ministry of Agriculture and Land Reclamation
General Organization for Veterinary Services

Epidemiology Planning Unit

Rift Valley Fever “RVF”

Document Prepared By EPU:

  • Dr. Amira Kamal
  • Dr. Ibrahim Elbindary
  • Dr. Salah Mahrous
  • Dr. Hassan Ibrahim
  • Dr. Sherine Galal

Revised By:
Dr. Moustafa Osman Ramadan
General Director of Preventive Medicine
Supervisor of Epidemiology Planning Unit

Supervised by:
Prof. Dr. M. S. Soliman
Supervisor of GOVS
Vice President of Cairo University

 

Rift Valley Fever

History of the disease in Egypt

The first appearance of RVF disease in Egypt on August 1977 in Aswan governorate then spread epidemically to other governorates causing high morbidity in different susceptible animals as cattle, buffalo, sheep and goats, camels and high mortality in young animals till 1980. It caused high losses in livestock industry which reached 82 millions L.E. In addition to human cases about 18000 cases with mortality of 598 cases. The disease stopped/perished and only 1 case appeared in 1980 followed by disappearance of the disease for 13 successive years till 1993.

Since that 1977 outbreak the disease was controlled by using local produced inactivated vaccine which covers only 20% of the susceptible animal population but increase to 40% on 2 years before 1993 due to increase in vaccine production.

A highly epidemic spread of the disease occurs in 1993 starting from Aswan governorate. That’s when GOVS started to use Mutigenic Living Rift Valley Fever Vaccine “MLRVF” to vaccinate all susceptible animals except pregnant ewes and goats and newly born animals. The disease stopped in 1994.

Control of the disease in Egypt

Control of blood sucking insects:

Periodical spraying of the animals and their premises by using safe insecticides to eradicate blood sucking insects.

Vaccination:

Periodical vaccination of susceptible animals (cattle, buffaloe, sheep, goat and camel) using local manufactured inactivated vaccine since 1978 for animals over 6M of age and a vaccination campaign for all governorates is held every 6 Months

Vaccination by Living mutigenic vaccine (MLRVF) has been used since 9/4/1994 and it gives immunity for around 3 years.

Serosurveillance:

Periodical Sero-surveillance of susceptible animals in different governorates twice per year to assess the immune status of vaccinated animals after vaccination campaigns held against the disease.

Quarantine measures:

Regular testing of camel and sheep imported from Sudan at the border veterinary quarantine stations in Daraw-Aswan and in the southern triangle area Shalatine, Halayeb and Aboramad.

Mutual Cooperation of different authorities:

GOVS cooperate with National Research Institutes (VSVRI, AHRI) Veterinary Faculties, NAMRU3 and Ministry of Health to control the disease.

 

Abbreviations:

VSVRI Veterinary Serum and Vaccine Research Institute

AHRI Animal Health Research Institute

EPU Epidemiology Planning Unit

GOVS General Organization for Veterinary Services

 

Table No “1”: Total No of vaccinated animals against RVF

From 1990 to 1998

Year

Cattle

Buffalo

Sheep

Goat

camel

Total

1990

710963

680609

432449

0

0

1,824,021

1991

596891

634276

712334

0

0

1,943,501

1992

874588

782362

1308882

0

0

2,965,832

1993

1454823

1174752

1998800

54550

845

4,683,770

1994

2356144

2175442

3144794

369950

12178

8,058,508

1995

883251

692725

1135696

144414

51233

2,907,319

1996

1146685

901340

1307751

256125

72272

11,397,480

1997

2250414

1919041

2717302

409465

78432

7,374,654

1998

2146401

1675742

2487830

545409

219272

7,074,654

 

 

Table No “2”: Total No of collected serum samples for Sero-Surveillance for assessing the Immune status of vaccinated animals against RVF From 1993 to 1998

Year

Total sample

Protected

Non protected

% protection

1993

5980

3498

2482

58.5%

1994

21421

16604

4817

77.5%

1996

2520

2407

113

95.5%

1997

5037

3455

1582

68.5%

1998

5112

4401

711

86.1%